CanAct CEGFR

Assay- Qualitative detection of mutations in EGFR gene

Kit used – “EasyPGX® ready EGFR” kit detects 85 mutations of the oncogene EGFR

Method used – Real-Time PCR

Sample type: FFPE (tumor cell content >20 %)

List of detectable mutations:

  1. EGFR G719x: the assay detects 4 mutations of codon 719 but does not distinguish between them
  2. EGFR T790M: the assay detects the T790M mutation
  3. EGFR S768I: the assay detects the S768I mutation
  4. EGFR ex20ins: the assay detects 11 mutations/insertions of the exon 20 of EGFR but does not distinguish between them
  5. EGFR L858R: the assay detects four L858R mutations
  6. EGFR L861Q: the assay detects the L861Q mutation
  7. EGFR ex19del: the assay detects the most frequent 64 deletions of the nucleotides of the exon 19 of EGFR but does not distinguish between them

*(not distinguishable between them)

 EGFR G719x * EGFR T790M EGFR S768I EGFR ex20ins * EGFR L858R * EGFR L861Q EGFR ex19del *
 ▪ G719S (2155G>A) ▪ T790M (2369C>T) ▪ S768I (2303G>T) ▪ V769_D770insASV (2307_2308insGCCAGCGTG)* ▪ L858R (2573T>G)* ▪ L861Q (2582T>A) ▪ E746_A750del (2235_2249del15)
▪ G719C (2155G>T) ▪ D770_N771insG (2310_2311insGGT)* ▪ L858R (2573_2574TG>GA) ▪ E746_A750del (2236_2250del15)
▪ G719A (2156G>C) ▪ H773_V774insH (2319_2320insCAC)* ▪ L858R (2573_2574TG>GT) ▪ L747_P753>S (2240_2257del18)
 ▪ G719fs*29 (2156G>-) ▪ V769_D770insASV# (2307_2308insGCCAGCGTG) ▪ L747_A750>P (2239_2248TTAAGAGAAG>C)
▪ V769_D770insASV (2296_2297insTGGCCAGCG)* ** ▪ E746_S752>V (2237_2255>T)
 ▪ V769_D770insASV (2308_2309insCCAGCGTGG) ▪ L747_T751del (2240_2254del15)
▪ V769_D770insASV (2309_2310AC>CCAGCGTGGAT)* ** ▪ L747_S752del (2239_2256del18)
▪ D770_N771>AGG (2309_2312ACAA>CTGGTGG)* ** ▪ E746_T751>A (2237_2251del15)
▪ N771>GY (2311A>GGTT)* **  ▪ L747_T751del (2239_2253del15)
▪ N771>SH (2311_2312insGTC)* ** ▪ L747_T751>P (2239_2251>C)
▪ N771>SGH (2311_2312insGTGGCC) ▪ L747_E749del (2239_2247del9)
▪ E746_E749del (2235_2246del12)
▪ L747_P753>Q (2239_2258>CA)
▪ L747_T751>S (2240_2251del12)
▪ E746_S752>A (2237_2254del18)
▪ L747_A750>P (2238_2248>GC)
▪ E746_S752>D (2238_2255del18)
 ▪ E746_T751>I (2235_2252>AAT)
▪ L747_T751>Q (2238_2252>GCA)
▪ E746_T751del (2236_2253del18)
▪ K745_E746insIPVAIK (2232_2233ins18) **
▪ K745_E746insIPVAIK (2234_2235ins18) **
▪ K745_E746insTPVAIK (2234_2235ins18) **
▪ E746_E749delELRE (2235_2246del12) **
▪ E746_A750>IP (2235_2248>AATTC) **
▪ E746_T751>IP (2235_2251>AG) **
▪ E746_T751delELREAT (2235_2252del18) **
▪ E746_S752>I (2235_2255>AAT) **
▪ E746delE (2234_2236delAGG) **
▪ E746_T751>S (2236_2251>T) **
▪ E746_A750>AP (2237_2248>CAC) **
▪ K745_E746insVPVAIK (2236_2237ins18) **
▪ E746_S752>V (2235_2255>GGT) **
▪ E746_T751>VP (2237_2251>TTC) **
▪ E746_T751>VA (2237_2253>TTGCT) **
▪ E746_S752>V (2237_2256>TT) **
▪ E746V (2237_2238AA>TT) **
 ▪ E746_T751>VP (2237_2253>TTCCT) **
▪ E746_P753>VQ (2237_2258>TTCA) **
▪ E746_A750>DP (2238_2249>TCC) **
▪ L747_T751>P (2238_2251>GC) **
▪ L747_S752>QH (2238_2255>GCAACA) **
▪ L747_S752>Q (2238_2256>GCAA) **
▪ L747_T751>A (2239_2253>GCT) **
▪ L747_K754delLREATSPK (2239_2262del24) **
▪ L747_A755>AN (2239_2264>GCCAA) **
▪ L747_K754>ANKG (2239_2262>GCCAACAAGGGA) **
▪ L747P (2239_2240TT>CC) **
▪ L747_A750>P (2239_2250>CCA) **
▪ L747_T751>PT (2239_2253>CCAACG) **
 ▪ L747_T751delLREAT (2238_2252del15) **
▪ L747_P753>S (2239_2257>T) **
▪ L747S (2240T>C) **
▪ L747_K754>ST (2240_2261>CGAC) **
▪ L747_A755>SKG (2240_2264>CGAAAGG) **
▪ L747_T751>Q (2239_2253>CAA) **
▪ L747_T751>Q (2239_2252>CA) **
▪ L747_S752>Q (2239_2256>CAA) **
▪ L747_S752>QH (2239_2256>CAACAT) **
▪ K745_E746insIPVAIK (2235_2236ins18) **
▪ L747_E749delLRE (2236_2244delGAATTAAGA) **
▪ L747_A750>P (2239_2250>CCG) **
▪ L747_A750>S (2240_2248del9) **
▪ L747_P753>Q (2239_2259>CAA) **

 

Limitations

Assay LOD C95 (at medium DNA input concentration)
G719x 5.0%
T790M 1.0%
S768I 0.5%
ex20ins 5.0%
L858R 1.0%
L861Q 1.0%
ex19del 0.5%

 

Disclaimer

This assay can detect only EGFR mutations mentioned above.

This assay’s accuracy depends on the sample’s quality, tumor content, and allele frequency.